RGS1 and related genes as potential targets for immunotherapy in cervical cancer: computational biology and experimental validation

BACKGROUND: Effective treatment is needed for advanced, inoperable, or chemotherapy-resistant cervical cancer patients. Immunotherapy has become a new treatment modality for cervical cancer patients, and there is an urgent need to identify additional targets for cervical cancer immunotherapy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Siyang, Wang, Han, Liu, Jiao, Tao, Tao, Zeng, Zhi, Wang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310486/
https://www.ncbi.nlm.nih.gov/pubmed/35879796
http://dx.doi.org/10.1186/s12967-022-03526-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310486/
https://www.ncbi.nlm.nih.gov/pubmed/35879796
http://dx.doi.org/10.1186/s12967-022-03526-0

Ejemplares similares